Cyclo Therapeutics, Inc. (CYTHW) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The company is headquartered in Gainesville, FL, United States. The current CEO is N. Scott Fine.
CYTHW has IPO date of 2020-12-18, 8 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $899.37K.
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
